距骨缺血性坏死的FAPI摄取
本文报道一例既往有肝脏受累的转移性去势抵抗性前列腺癌患者接受177Lu-PSMA治疗,第三周期后扫描见左踝非典型摄取,68Ga-FAPI-46 PET/CT再分期亦显示FAPI摄取,经MRI证实为距骨缺血性坏死,提示177Lu-PSMA-617与68Ga-FAPI-46在距骨缺血性坏死中可出现假阳性摄取。
要点
- 177Lu-PSMA-617治疗后扫描左踝非典型摄取需警惕假阳性。
- 68Ga-FAPI-46 PET/CT在距骨缺血性坏死中也可出现FAPI摄取。
- MRI可用于鉴别距骨缺血性坏死所致的假阳性摄取。
核心结论
- 距骨缺血性坏死可导致177Lu-PSMA-617和68Ga-FAPI-46假阳性摄取。
研究设计与样本
- 本文为单例病例报告,描述一例mCRPC患者接受177Lu-PSMA治疗后的影像学发现。
主要发现
- 第三周期177Lu-PSMA治疗后扫描见左踝非典型摄取。
- 68Ga-FAPI-46 PET/CT再分期亦见左踝FAPI摄取。
- MRI证实左踝病变为距骨缺血性坏死。
临床怎么用
- 对177Lu-PSMA或FAPI PET/CT中非典型骨摄取应结合MRI鉴别缺血性坏死等良性病变。
局限性
- 单例病例报告,结论的普遍性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a case of metastatic castration-resistant prostate cancer (mCRPC) with prior hepatic involvement who ultimately received 177 Lu-PSMA therapy. During the posttreatment scan following the third cycle, atypical uptake was observed in the left ankle, which was also evident as FAPI uptake on the 68 Ga-FAPI-46 PET/CT performed for restaging, and was subsequently confirmed as avascular necrosis through MRI correlation. This case illustrates the false-positive uptake of 177 Lu-PSMA-617 and 68 Ga-FAPI-46 in avascular necrosis of the talus.
引用
- Saber Tanha A, Raeisi N, Karamian F, et al. FAPI Uptake in Avascular Necrosis of the Talus. Clin Nucl Med. 2026. PMID: 41642049. doi:10.1097/RLU.0000000000006197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。